<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02963636</url>
  </required_header>
  <id_info>
    <org_study_id>106238</org_study_id>
    <nct_id>NCT02963636</nct_id>
  </id_info>
  <brief_title>Proximity Work in Family Medicine Groups : the Impact of Pharmacists</brief_title>
  <acronym>FMG</acronym>
  <official_title>Proximity Work in Family Medicine Groups : the Impact of Pharmacists</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>McGill University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fonds de la Recherche en Santé du Québec</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Université de Sherbrooke</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Laval University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The project objective is to evaluate the impact of the recent addition of pharmacists within
      family medicine groups (FMGs) on organizational and clinical parameters. The process by which
      changes occur and the level of pharmacists' activities will also be assessed. The ultimate
      goal of the project is the development of an accompanying guide to facilitate the work of the
      pharmacist in monitoring complex patients in primary care medical clinics.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of drug related problems</measure>
    <time_frame>3 to 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Regimen complexity</measure>
    <time_frame>3 to 6 months</time_frame>
    <description>Medication regimen complexity index (MRCI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication adherence</measure>
    <time_frame>3 to 6 months</time_frame>
    <description>Proportion of days covered (PDC)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of care provided by the clinical team (pharmacists, doctors, nurses, etc.)</measure>
    <time_frame>3 to 6 months</time_frame>
    <description>Quality indicators (proposed by INESSS)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">62</enrollment>
  <condition>Health Services</condition>
  <arm_group>
    <arm_group_label>Pharmacist clinical intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients exposed to the pharmacist intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pharmacist clinical intervention</intervention_name>
    <description>Pharmacists will make a clinical intervention with patients. They will review patient drug therapy already prescribed in their usual care. This includes a medication reconciliation, an assessment of drug related problems, an assessment of the regimen complexity and adherence to treatment. A care plan will be elaborated. Moreover, immediate and future interventions with the patient or other health professionals will be implemented and monitored. There will be no drug or devices tested, it is a human clinical intervention by a pharmacist.</description>
    <arm_group_label>Pharmacist clinical intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Willing to meet with the pharmacist and;

          -  Consuming drugs of four or more different pharmacological classes or having to take at
             least four doses per day and;

          -  aged 70 or over with at least two criteria of vulnerability or aged less than 70 with
             at least 3 criteria of vulnerability or had a recent loss of autonomy or in post-
             hospitalization with medication changes in the hospital.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CIUSSS de la Capitale-Nationale</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 17, 2016</study_first_submitted>
  <study_first_submitted_qc>November 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2016</study_first_posted>
  <last_update_submitted>November 14, 2016</last_update_submitted>
  <last_update_submitted_qc>November 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Laval University</investigator_affiliation>
    <investigator_full_name>Line Guénette</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>family medicine group</keyword>
  <keyword>pharmacists</keyword>
  <keyword>primary health care</keyword>
  <keyword>pharmaceutical services</keyword>
  <keyword>interprofessional relations</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

